About Journal of Personalized Medicine
Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. JPM publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., precision medicine, pharmacogenomics/proteomics, systems biology, ‘omics association analysis).
For a comprehensive perspective of primary research, commentaries, and reviews related to personalized medicine, also termed precision medicine, JPM aims to integrate expertise from the molecular and translational sciences, therapeutics and diagnostics, as well as discussions of regulatory, social, ethical and policy aspects. We provide a forum to bring together academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities.
Topics of interest with a view towards personalized medicine include (but are not limited to) the following:
- Omics-based studies of disease risk, disease prognosis, and response to therapy
- Biomarker identification and application
- Drug target discovery and integration with individualized therapy
- Pharmacogenomics – genetics and biochemistry of drug uptake, action, and metabolism
- Prediction-based drug safety
- Novel therapeutics: genetic-based, nanotechnology, targeting strategies
- Advancements in Technologies and Resources
- Genetic testing, sequencing technologies, and molecular diagnostics
- Expression analysis, metabolomics, proteomics
- Genome-wide association studies
- Bioinformatics and health informatics
- Personalization of omics-based non-drug related health interventions
- Regulation and bioethics in personalized medicine
MDPI Publication Ethics Statement
JPM is a member of the Committee on Publication Ethics (COPE). MDPI takes the responsibility to enforce a rigorous peer-review together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, inappropriate authorship credit, and the like, do arise. MDPI takes such publishing ethics issues very seriously and our editors are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use iThenticate to check submissions against previous publications. MDPI works with Publons to provide reviewers with credit for their work.
Authors and publishers are encouraged to send review copies of their recent related books to the following address. Received books will be listed as Books Received within the journal's News & Announcements section.
St. Alban-Anlage 66
Copyright / Open Access
Articles published in JPM will be Open-Access articles distributed under the terms and conditions of the Creative Commons Attribution License (CC BY). MDPI will insert the following note at the end of the published text:
Reprints may be ordered. Please contact email@example.com for more information on how to order reprints. Announcements regarding academic activities such as conferences are published for free. Advertisement can be either published or placed on the pertinent website. Contact e-mail address is firstname.lastname@example.org. For further MDPI contacts, see here.
Announcement and Advertisement
MDPI Barcelona office, Avenida Madrid, 95, 08028 Barcelona, Spain
Reprints may be ordered. Please contact email@example.com for more information on how to order reprints.
Announcements regarding academic activities such as conferences are published for free. Advertisement can be either published or placed on the pertinent website. Contact e-mail address is firstname.lastname@example.org.
For further MDPI contacts, see here.